​

Penumbra (PEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PEN Stock Forecast

Penumbra (PEN) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $371.92, with a high of $388.00 and a low of $349.00. This represents a 10.25% increase from the last price of $337.35.

$150 $200 $250 $300 $350 $400 High: $388 Avg: $371.92 Low: $349 Last Closed Price: $337.35

PEN Stock Rating

Penumbra stock's rating consensus is Hold, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (40.91%), 13 Hold (59.09%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 22 0 13 9 Strong Sell Sell Hold Buy Strong Buy

PEN Price Target Upside V Benchmarks

TypeNameUpside
StockPenumbra10.25%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks31.16%

Price Target Trends

1M3M12M
# Anlaysts21229
Avg Price Target$367.00$367.92$345.76
Last Closing Price$337.35$337.35$337.35
Upside/Downside8.79%9.06%2.49%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 262214--18
Feb, 2622131-18
Jan, 264131-119
Dec, 253133-120
Nov, 253133-120
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 26, 2026Priya SachdevaUBS$374.00$340.249.92%10.86%
Feb 25, 2026Evercore ISI$360.00$338.706.29%6.71%
Jan 20, 2026RBC Capital$374.00$350.786.62%10.86%
Jan 20, 2026Canaccord Genuity$374.00$350.786.62%10.86%
Jan 16, 2026Jefferies$374.00$350.986.56%10.86%
Jan 16, 2026David RescottRobert W. Baird$374.00$350.496.71%10.86%
Jan 16, 2026Mike KratkyLeerink Partners$374.00$350.496.71%10.86%
Jan 16, 2026Richard NewitterTruist Financial$374.00$350.496.71%10.86%
Jan 15, 2026Ryan ZimmermanBTIG$349.00$350.49-0.43%3.45%
Jan 15, 2026Wells Fargo$374.00$351.276.47%10.86%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 26, 2026UBSNeutralNeutralhold
Feb 25, 2026Evercore ISIOutperformOutperformhold
Jan 20, 2026RBC CapitalOutperformSector Performdowngrade
Jan 16, 2026NeedhamBuyHolddowngrade
Jan 16, 2026JefferiesHoldHolddowngrade
Jan 16, 2026Leerink PartnersMarket Performdowngrade
Jan 15, 2026BTIGBuyNeutraldowngrade
Jan 15, 2026CitigroupBuyNeutraldowngrade
Jan 15, 2026William BlairMarket Performdowngrade
Jan 15, 2026Piper SandlerOverweightNeutraldowngrade

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 $7 $8 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.14$-0.05$2.37$0.36$4.57---
Avg Forecast$0.81$0.15$2.03$2.79$3.80$4.96$6.32$7.56
High Forecast$0.83$0.16$2.20$2.97$4.37$5.83$6.87$7.72
Low Forecast$0.80$0.15$1.90$2.68$3.49$4.46$5.76$7.35
Surprise %-82.72%-133.33%16.75%-87.10%20.26%---

Revenue Forecast

$500M $900M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$747.59M$847.13M$1.06B$1.19B$1.40B---
Avg Forecast$738.09M$843.69M$1.06B$1.19B$1.36B$1.56B$1.76B$1.98B
High Forecast$753.42M$854.36M$1.08B$1.20B$1.38B$1.56B$1.77B$2.01B
Low Forecast$727.97M$829.90M$1.04B$1.17B$1.34B$1.56B$1.75B$1.93B
Surprise %1.29%0.41%-0.20%0.33%3.08%---

Net Income Forecast

$-50M $30M $110M $190M $270M $350M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.28M$-2.00M$90.95M$14.01M$177.69M---
Avg Forecast$-4.05M$-34.15M$90.95M$110.92M$146.01M$192.40M$260.55M$296.48M
High Forecast$8.84M$-22.81M$120.73M$116.57M$171.28M$228.83M$269.26M$302.75M
Low Forecast$-16.95M$-45.49M$61.17M$105.26M$136.95M$175.08M$226.04M$288.28M
Surprise %-230.38%-94.14%--87.37%21.70%---

PEN Forecast FAQ

Is Penumbra stock a buy?

Penumbra stock has a consensus rating of Hold, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 13 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Penumbra is a neutral investment for most analysts.

What is Penumbra's price target?

Penumbra's price target, set by 22 Wall Street analysts, averages $371.92 over the next 12 months. The price target range spans from $349 at the low end to $388 at the high end, suggesting a potential 10.25% change from the previous closing price of $337.35.

How does Penumbra stock forecast compare to its benchmarks?

Penumbra's stock forecast shows a 10.25% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (31.16%).

What is the breakdown of analyst ratings for Penumbra over the past three months?

  • March 2026: 11.11% Strong Buy, 11.11% Buy, 77.78% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 11.11% Strong Buy, 11.11% Buy, 72.22% Hold, 5.56% Sell, 0% Strong Sell.
  • January 2026: 21.05% Strong Buy, 68.42% Buy, 5.26% Hold, 0% Sell, 5.26% Strong Sell.

What is Penumbra’s EPS forecast?

Penumbra's average annual EPS forecast for its fiscal year ending in December 2026 is $4.96, marking a 8.53% increase from the reported $4.57 in 2025. Estimates for the following years are $6.32 in 2027, and $7.56 in 2028.

What is Penumbra’s revenue forecast?

Penumbra's average annual revenue forecast for its fiscal year ending in December 2026 is $1.56B, reflecting a 10.86% increase from the reported $1.4B in 2025. The forecast for 2027 is $1.76B, and $1.98B for 2028.

What is Penumbra’s net income forecast?

Penumbra's net income forecast for the fiscal year ending in December 2026 stands at $192.4M, representing an 8.28% increase from the reported $177.69M in 2025. Projections indicate $260.55M in 2027, and $296.48M in 2028.